| A global reference for human genetic variation 1000 Genomes Project Consortium Nature 526 (7571), 68, 2015 | 15532 | 2015 |
| Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival TJ Curiel, G Coukos, L Zou, X Alvarez, P Cheng, P Mottram, ... Nature medicine 10 (9), 942-949, 2004 | 6352 | 2004 |
| Cancer immunotherapy comes of age I Mellman, G Coukos, G Dranoff Nature 480 (7378), 480-489, 2011 | 4400 | 2011 |
| Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer L Zhang, JR Conejo-Garcia, D Katsaros, PA Gimotty, M Massobrio, ... New England journal of medicine 348 (3), 203-213, 2003 | 3981 | 2003 |
| Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance F Martins, L Sofiya, GP Sykiotis, F Lamine, M Maillard, M Fraga, ... Nature reviews Clinical oncology 16 (9), 563-580, 2019 | 1753 | 2019 |
| Regulatory CD4+ CD25+ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer EY Woo, CS Chu, TJ Goletz, K Schlienger, H Yeh, G Coukos, SC Rubin, ... Cancer research 61 (12), 4766-4772, 2001 | 1615 | 2001 |
| Rethinking ovarian cancer: recommendations for improving outcomes S Vaughan, JI Coward, RC Bast Jr, A Berchuck, JS Berek, JD Brenton, ... Nature Reviews Cancer 11 (10), 719-725, 2011 | 1537 | 2011 |
| microRNAs exhibit high frequency genomic alterations in human cancer L Zhang, J Huang, N Yang, J Greshock, MS Megraw, A Giannakakis, ... Proceedings of the National Academy of Sciences 103 (24), 9136-9141, 2006 | 1414 | 2006 |
| Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells A Facciabene, X Peng, IS Hagemann, K Balint, A Barchetti, LP Wang, ... Nature 475 (7355), 226-230, 2011 | 1408 | 2011 |
| The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis Q Huang, K Gumireddy, M Schrier, C Le Sage, R Nagel, S Nair, DA Egan, ... Nature cell biology 10 (2), 202-210, 2008 | 1239 | 2008 |
| Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ... Nature reviews Cancer 15 (11), 668-679, 2015 | 1219 | 2015 |
| Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors GT Motz, SP Santoro, LP Wang, T Garrabrant, RR Lastra, IS Hagemann, ... Nature medicine 20 (6), 607-615, 2014 | 981 | 2014 |
| Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments I Kryczek, M Banerjee, P Cheng, L Vatan, W Szeliga, S Wei, E Huang, ... Blood, The Journal of the American Society of Hematology 114 (6), 1141-1149, 2009 | 978 | 2009 |
| T-regulatory cells: key players in tumor immune escape and angiogenesis A Facciabene, GT Motz, G Coukos Cancer research 72 (9), 2162-2171, 2012 | 923 | 2012 |
| Laser-capture microdissection V Espina, JD Wulfkuhle, VS Calvert, A VanMeter, W Zhou, G Coukos, ... Nature protocols 1 (2), 586-603, 2006 | 915 | 2006 |
| Consensus guidelines for the definition, detection and interpretation of immunogenic cell death L Galluzzi, I Vitale, S Warren, S Adjemian, P Agostinis, AB Martinez, ... Journal for immunotherapy of cancer 8 (1), 2020 | 872 | 2020 |
| Modulation of the antitumor immune response by complement MM Markiewski, RA DeAngelis, F Benencia, SK Ricklin-Lichtsteiner, ... Nature immunology 9 (11), 1225-1235, 2008 | 845 | 2008 |
| Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors J Duraiswamy, KM Kaluza, GJ Freeman, G Coukos Cancer research 73 (12), 3591-3603, 2013 | 808 | 2013 |
| Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer L Zhang, S Volinia, T Bonome, GA Calin, J Greshock, N Yang, CG Liu, ... Proceedings of the National Academy of Sciences 105 (19), 7004-7009, 2008 | 708 | 2008 |
| Deciphering and reversing tumor immune suppression GT Motz, G Coukos Immunity 39 (1), 61-73, 2013 | 705 | 2013 |
